GGrantIndex
Sort

17,054 grants matching genome editing

Organizational and Cultural Dynamics in Genomics Companies: Industry Engagement in Navigating Social and Ethical Issues

$249,000
Alexis Walker · Columbia University Health Sciences · R00 · FY2023 · HG

The alternative roles of Neisseria CRISPR-Cas9 in endogenous gene regulation and bacterial physiology

$249,000
Yan Zhang · University Of Michigan At Ann Arbor · R00 · FY2018 · GM

Elucidating the role of support signaling in promoting minimal residual disease in mouse models of oncogene-driven lung cancer

$249,000
Aria Vaishnavi · University Of Tx Md Anderson Can Ctr · R00 · FY2023 · CA

A universal genome editing strategy to develop an airway stem cell therapy for cystic fibrosis

$249,000
Sriram Vaidyanathan · Research Inst Nationwide Children'S Hosp · R00 · FY2024 · HL

Molecular mechanisms regulating chromatin looping in time and space

$249,000
Anders Sejr Hansen · Massachusetts Institute Of Technology · R00 · FY2020 · GM

Quantifying the sources and dynamics of tumor growth variability using Tuba-seq

$249,000
Christopher Dennis McFarland · Case Western Reserve University · R00 · FY2022 · CA

In vivo precision genome editing to correct genetic disease

$249,000
Gregory A. Newby · Johns Hopkins University · R00 · FY2023 · HL

An integrated approach to the study of mitochondrial vitamin B12 pathway and type II fatty acid synthesis

$249,000
Hongying Shen · Yale University · R00 · FY2020 · GM

Molecular mechanisms of memory formation and tolerance in CRISPR-Cas systems

$249,000
Naama Aviram · Sloan-Kettering Inst Can Research · R00 · FY2025 · GM

Dissecting the role of clonal evolution in NPM1-mutant AML

$249,000
Linde A Miles · Cincinnati Childrens Hosp Med Ctr · R00 · FY2022 · CA

Developing Remyelination Strategies for Demyelinating Optic Neuropathies Using Human Pluripotent Stem Cells

$249,000
Xitiz Chamling · Johns Hopkins University · R00 · FY2022 · EY

Transcriptional networks controlling molting in C. elegans and B. malayi

$249,000
Jordan David Ward · University Of California Santa Cruz · R00 · FY2017 · GM

Mechanisms that Enhance and Suppress HIV-1 Resistance in Gene Edited Primary Human Cells

$249,000
Amanda M Dudek · University Of Iowa · R00 · FY2025 · HL

Epigenetic activation of the interferon response to sensitize cancers to immune therapy

$249,000
Katherine B Chiappinelli · George Washington University · R00 · FY2018 · CA

Mechanisms of centrosome regulation

$249,000
Dorothy A Lerit · Emory University · K22 · FY2019 · HL

Functional characterization of novel oncogenic loci driving progression and immune response in gastrointestinal cancer

$249,000
Yuan-Hung Lo · University Of Tx Md Anderson Can Ctr · R00 · FY2023 · CA

Functional dissection of oncogenic enhancers

$249,000
Daniel Herranz · Rbhs -Cancer Institute Of New Jersey · R00 · FY2019 · CA

Quantifying the sources and dynamics of tumor growth variability using Tuba-seq

$249,000
Christopher Dennis McFarland · Case Western Reserve University · R00 · FY2021 · CA

Mechanisms of centrosome regulation

$249,000
Dorothy A Lerit · Emory University · K22 · FY2018 · HL

Discovery of novel phage-bacterial interactions

$249,000
Nicole D. Marino · University Of Pennsylvania · R00 · FY2024 · GM

Large-scale CRISPR screening of essential calcium-related genes in the human parasite Tr. cruzi

$249,000
Noelia Lander · University Of Cincinnati · R00 · FY2022 · AI

Intrinsic and innate barriers to respiratory virus infections

$249,000
Meike Dittmann · New York University School Of Medicine · R00 · FY2017 · AI

Coupling promoter choice and alternative RNA splicing in the mammalian Protocadherin gene cluster

$249,000
Daniele Canzio · University Of California, San Francisco · R00 · FY2019 · GM

The alternative roles of Neisseria CRISPR-Cas9 in endogenous gene regulation and bacterial physiology

$249,000
Yan Zhang · University Of Michigan At Ann Arbor · R00 · FY2017 · GM

In vivo precision genome editing to correct genetic disease

$249,000
Gregory A. Newby · Johns Hopkins University · R00 · FY2024 · HL